Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
8.73
-0.15 (-1.69%)
Jul 8, 2025, 4:00 PM - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $5.13 million as of July 8, 2025. Its market cap has increased by 105.39% in one year.
Market Cap
5.13M
Enterprise Value
-3.64M
1-Year Change
105.39%
Ranking
Category
Stock Price
$8.73
Market Cap Chart
Since August 1, 2016, Quoin Pharmaceuticals's market cap has decreased from $28.60M to $5.13M, a decrease of -82.05%. That is a compound annual growth rate of -17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2025 | 9.00M | 172.73% |
| Dec 31, 2024 | 3.30M | -31.25% |
| Dec 29, 2023 | 4.80M | -30.43% |
| Dec 30, 2022 | 6.90M | -54.61% |
| Dec 31, 2021 | 15.20M | 80.95% |
| Dec 31, 2020 | 8.40M | 68.00% |
| Dec 31, 2019 | 5.00M | -60.32% |
| Dec 31, 2018 | 12.60M | -66.58% |
| Dec 29, 2017 | 37.70M | 125.75% |
| Dec 30, 2016 | 16.70M | -41.61% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 693.83B |
| Johnson & Johnson | 373.59B |
| AbbVie | 331.43B |
| Novo Nordisk | 308.12B |
| UnitedHealth Group | 275.51B |
| Novartis AG | 240.05B |
| Abbott Laboratories | 232.62B |
| AstraZeneca | 216.19B |